Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA

Mitigation of the ongoing coronavirus disease 2019 (COVID-19) pandemic requires reliable and accessible laboratory diagnostic services. In this study, the performance of one laboratory-developed test (LDT) and two commercial tests, cobas SARS-CoV-2 (Roche) and Amplidiag COVID-19 (Mobidiag), were eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Mannonen, Laura, Kallio-Kokko, Hannimari, Loginov, Raisa, Jääskeläinen, Anu, Jokela, Pia, Antikainen, Jenni, Väre, Paula, Kekäläinen, Eliisa, Kurkela, Satu, Jarva, Hanna, Lappalainen, Maija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. 2021
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825913/
https://www.ncbi.nlm.nih.gov/pubmed/33486074
http://dx.doi.org/10.1016/j.jmoldx.2021.01.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825913/
https://www.ncbi.nlm.nih.gov/pubmed/33486074
http://dx.doi.org/10.1016/j.jmoldx.2021.01.005

Ejemplares similares